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Background/aim: This study aimed to evaluate the effects of salbutamol inhaler treatment in an experimentally induced model of
pulmonary contusion.
Materials and methods: Thirty-two male Wistar albino rats were randomly divided into four groups: the control group (CG), sham
group (SG), treatment group 1 (TG1), and treatment group 2 (TG2). Experimental contusion was established by targeting the right lung
tissue. After 72 h, histopathological evaluation for the severity of edema, hemorrhage, and leukocyte infiltration was performed in both
sides of the lungs.
Results: Examination of right lung tissues revealed a significant difference in edema, hemorrhage, leukocyte infiltration, and total lung
injury scores between the CG and SG. Both TG1 and TG2 had less edema, hemorrhage, and leukocyte infiltration and lower total lung
injury scores compared with the SG. There was no significant difference in edema, hemorrhage, and total lung injury scores between
the CG and TG1 or TG2. A significant difference in hemorrhage scores between the SG and TG1 and edema scores between the SG and
TG2 was observed, with treatment groups having lower values. A significant difference in total lung injury score was also found between
SG and TG1.
Conclusion: Salbutamol inhaler therapy during pulmonary contusion may prevent complications by reducing edema, hemorrhage,
leukocyte infiltration, and total lung injury score.
Key words: Experimental, pulmonary contusion, lung, salbutamol, inhalation, trauma

1. Introduction
Pulmonary contusion (PC) is the most common childhood
injury following thoracic trauma (1). The clinical process
of PC cases may be either entirely normal or too severe
for mechanical ventilation. Accordingly, pulmonary
parenchymal injury leads to the development of
interstitial/intraalveolar edema, perivascular/intraalveolar
hemorrhage, and inflammation, which are responsible
for the progressive complications that develop in the
process (2). Patients with PC may present with symptoms
appearing normal during the early posttraumatic period
and developing within 24 h (3). As such, delaying the
progression of edema, hemorrhage, and inflammation
with prompt treatment during the early periods following
PC can prevent complications and morbidity. In the
literature, several clinical and experimental studies have
used different medical treatment agents for this purpose
(4,5).

Salbutamol, a short-acting β2-adrenergic receptor
agonist, has been used for its bronchodilatory effect
in obstructive airway disease (6). Its main mechanism
of action involves activating β-adrenergic receptors,
causing smooth muscles in the bronchi to relax. Other
important mechanisms of action of salbutamol include
suppressing the release of inflammatory mediators
from mast cells, decreasing microvascular permeability,
and increasing mucociliary function (7). Stimulation
of β-adrenergic receptors with β2-adrenergic agonists
regulates alveolar cells, thereby decreasing alveolar
edema (8). In their in vivo and in vitro studies, Perkins
et al. reported that salbutamol may contribute to
epithelial repair, may affect neutrophil function, and
may be used in the treatment of acute respiratory
distress syndrome (9,10). In many studies, salbutamol
has also been shown to have inflammation-reducing
effects in the lungs (11).
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2.3. Histopathological examination
Rats were sacrificed 72 h after the experimental procedure
and lung tissues were examined histopathologically.
Tissue samples from both lungs were fixed with 10%
neutral buffered formalin and embedded in paraffin.
Interstitial/intraalveolar edema, perivascular/intraalveolar
hemorrhage, and perivascular/interstitial leukocyte
infiltration were evaluated under a light microscope
(Olympus BX51, USA) with hematoxylin & eosin stain by
the same pathologist who was blinded to the study. The
scoring system was such that the absence of such features
was awarded 0 points, whereas mild grade with 25% lung
parenchyma involvement, moderate grade with 50% lung
parenchyma involvement, and severe grade with 75% lung
parenchyma involvement were awarded 1, 2, and 3 points,
respectively. The total lung injury score was calculated by
the obtained findings (14).
2.4. Statistical analysis
Data were analyzed using IBM SPSS 23 (IBM Corp.,
Armonk, NY, USA). The Kruskal–Wallis test was used to
compare intergroup measurements, whereas the Wilcoxon
test was used for intragroup comparisons. Analysis results
were presented as frequency (%). P ≤ 0.05 indicated
statistical significance

The present experimental study evaluates the
histopathological effects of salbutamol, a β2-agonist, on
pulmonary parenchyma in an experimental model of PC
in rats.
2. Materials and methods
The current study was approved by the Animal
Experimentation Ethics Committee of Ondokuz
Mayıs University (Approval No. 2017/50). All surgical
procedures were performed at the Research Center for
Animal Experiments at Ondokuz Mayıs University. All
rats were individually caged in a room under standard
environmental conditions and fed with standard rat diet.
2.1. Experimental groups
A total of 32 Wistar albino rats weighing 280–300 g were
randomly divided into four groups (Table 1): the control
group (CG) (n = 8) (no intervention performed), sham
group (SG) (n = 8) (no treatment provided following
experimental contusion), treatment group 1 (TG1)
(n = 8) (100 μg per dose of salbutamol inhaler treatment
administered once every 4 h for 24 h), and treatment group
2 (TG2) (100 μg per dose of salbutamol inhaler treatment
administered once every 4 h for 72 h) (12).
2.2. Experimental protocols
Rats in the SG, TG1, and TG2 were intraperitoneally
injected with a mixture of 80 mg/kg ketamine (Ketalar,
Pfizer, Turkey) and 12 mg/kg xylazine (Rompun, Bayer,
Turkey) after 8 h of fasting to achieve anesthesia. In the
establishment of PC, the weight reduction method defined
by Raghavendran et al. (13) was applied. The right lung
anatomy of each rat was marked, targeting the right
anterior axillary line–sternum–clavicle. Using a prepared
device, a 500-g metal cylinder was lowered from a height
of 40 cm to a protective silicone shield placed over the
marked area of the rat’s chest. According to the formula
E = mgh, an energy of 1.96 J was applied to the chest area
[E: energy (J), m: mass of the cylinder in kg, g: gravitational
constant (9.8 m/s2), h: height (m)].

3. Results
Histopathological pictures of the groups are shown in
Figure 1. Interstitial/intraalveolar edema scores for right
lung tissues according to group are shown in Figure 2. In
the CG, 75% (n = 6) and 25% (n = 2) of the specimens
received a score of 0 and 1, respectively. In the SG, 50%
(n = 4) received a score of 1, whereas 50% (n = 4) received
a score of 2. In TG1, 75% (n = 6) and 25% (n = 2) of the
specimens received a score of 1 and 2, respectively. In
TG2, all of the specimens (100%) received a score of 1. A
statistically significant difference was found between the
CG and SG but not between the CG and TG1 or TG2. No
statistically significant difference was observed between

Table 1. Experimental groups (CG: control group, SG: sham group, TG1: treatment group 1, TG2: treatment
group 2).
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Group

Number

Pulmonary
contusion

Salbutamol
treatment

Route of
administration

Duration of
administration

Group 1 (CG)

8

-

-

-

Group 2 (SG)

8

+

-

-

Group 3 (TG1)

8

+

+

Inhaler

24 h

Group 4 (TG2)

8

+

+

Inhaler

72 h

DEMİREL et al. / Turk J Med Sci

Figure 1. Histopathological evaluation of right lung tissues. Top left: Control group, mild interstitial congestion and
slight edema in the lung (H&E, 100×). Top right: Sham group, severe leukocyte infiltration, alveolar and interstitial
congestion, and edema (H&E, 400×). Bottom left: Treatment group 1, moderate leukocyte infiltration, alveolar and
interstitial congestion, and edema (H&E, 400×). Bottom right: Treatment group 2, mild leukocyte infiltration, alveolar
and interstitial congestion, and edema (H&E, 200×).
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Figure 2. Interstitial/intraalveolar edema distribution according to group (CG: control group, SG: sham group,
TG1: treatment group 1, TG2: treatment group 2).
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SG and TG1, though a statistically significant difference
was found between SG and TG2 (Table 2).
Interstitial/intraalveolar hemorrhage scores for right
lung tissues according to group are shown in Figure 3. In
the CG, 75% (n = 6) and 25% (n = 2) of the specimens
received a score of 0 and 1, respectively. In the SG, 12.5%
(n = 1), 75% (n = 6), and 12.5% (n = 1) of the specimens
received a score of 1, 2, and 3, respectively. In TG1, all of
the specimens received a score of 1. In TG2, 87.5% (n = 7)
and 12.5% (n = 1) of the specimens received scores of 1 and
2, respectively. Statistical analysis revealed a statistically
significant difference between the CG and SG but not
between the CG and TG1 or TG2. Although no statistically
significant difference was found between the SG and TG2,
a significant difference was observed between the SG and
TG1 (Table 3).

Polymorphonuclear leukocyte scores for right lung
tissues according to group are shown in Figure 4. In the
CG, 75% (n = 6) and 25% (n = 2) of the specimens received
scores of 0 and 1, respectively. In the SG, 75% (n = 6) and
25% (n = 2) of the specimens received scores of 1 and 2,
respectively. In TG1, 12.5% (n = 1) and 87.5% (n = 7) of
the specimens received scores of 0 and 1, respectively.
In TG2, all of the specimens (100%) received a score of
1. Statistical analysis revealed a statistically significant
difference between the CG and SG or TG2 but not between
the CG and TG1. No statistically significant difference was
found between the SG and TG1 or TG2 (Table 4).
Total lung injury scores and their statistical
analysis for right lung tissues according to
groups are shown in Table 5 and Figure 5. In the CG, 75%
(n = 6) and 25% (n = 2) of the specimens received scores

Table 2. Statistical comparison of interstitial/intraalveolar edema scores for right lung
tissues according to group (1: control group, 2: sham group, 3: treatment group 1, 4:
treatment group 2).
Groups

Score
0

1a

2b

3ab

4a

6 (75%)

---

---

---

1

2 (25%)

4 (50%)

6 (75%)

8 (100%)

2

---

4 (50%)

2 (25%)

---

P

<0.001

: No significant difference was found between groups with the same letter.

a, b

8
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7

number of rats

6

7
6

6

5

0

4
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2
1
0

1
2

2
1
0
CG

0

1

0

0
SG

3

1
0
TG1

0

0

0
TG2

Groups
Figure 3. Perivascular/intraalveolar hemorrhage distribution according to group (CG: control group, SG: sham
group, TG1: treatment group 1, TG2: treatment group 2).
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Table 3. Statistical comparison of perivascular/intraalveolar hemorrhage scores for right
lung tissue according to group (1: control group, 2: sham group, 3: treatment group 1,
4: treatment group 2).
Groups

Score

1a

2b

3a

P

4ab

0

6 (75%)

---

---

---

1

2 (25%)

1 (12.5%)

8 (100%)

7 (87.5%)

2

---

6 (75%)

---

1 (12.5%)

3

---

1 (12.5%)

---

---

<0.001

: No significant difference was found between groups with the same letter.

a, b

8

8
7

number of rats

6

7
6

6

5

0

4

1

3

2

2

2

2

3

1

1

0

0

0

0

CG

0

0

SG

0

0

0

TG1

0

TG2

Groups
Figure 4. Polymorphonuclear leukocyte infiltration distribution according to group (CG: control group, SG:
sham group, TG1: treatment group 1, TG2: treatment group 2).
Table 4. Statistical comparison of polymorphonuclear leukocyte infiltration scores for
right lung tissue according to group (1: control group, 2: sham group, 3: treatment group
1, 4: treatment group 2).

Score
0

Groups
1a

2b

3ab

4b

6 (75%)

---

1 (12.5%)

---

1

2 (25%)

6 (75%)

7 (87.5%)

8 (100%)

2

---

2 (25%)

---

---

P

<0.001

: No significant difference was found between groups with the same letter.

a, b

of 0 and 3, respectively. In the SG, 62.5% (n = 5) of the
specimens received a score of 5 and 12.5% (n = 1 each) of
the specimens received scores of 3, 4, and 6. In TG1, 12.5%

(n = 1), 62.5% (n = 5), and 25% (n = 2) of the specimens
received scores of 2, 3, and 4, respectively. In TG2, 87.5%
(n = 7) and 12.5% (n = 1) of the specimens received scores
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Table 5. Total lung injury scores and their statistical analysis for groups (CG: control group, SG:
sham group, TG1: treatment group 1, TG2: treatment group 2, Q: quartile).
Median

Q1

Q3

Min

Max

CG

0.0

a

0.0

2.3

0.0

3.0

SG

5.0

b

4.3

5.0

3.0

6.0

TG1

3.0ab

3.0

3.3

2.0

4.0

TG2

3.0a

3.0

3.0

3.0

4.0

P

<0.001

: No significant difference was found between groups with the same letter.

a, b

8
7

number of rats

6

7
6
0

5

5

1

4

2

3

3
2

2
1
0

4

0 0

0 0 0
CG

5

1

1
0 0
SG

6

0 0 0
TG1

TG2

Groups
Figure 5. Total lung injury score distribution according to group (CG: control group, SG: sham group, TG1:
treatment group 1, TG2: treatment group 2).

of 3 and 4, respectively. A statistically significant difference
was found between the CG and SG but not between the
CG and TG1 or TG2. No statistically significant difference
was observed between SG and TG1, though a statistically
significant difference was found between SG and TG2.
After intragroup comparison for right and left lung
tissues, perivascular/intraalveolar hemorrhage scores
differed only in the SG (P = 0.020). After examining for
left lung hemorrhage scores in the SG, 87.5% (n = 7) and
12.5% (n = 1) received scores of 1 and 2, respectively.
4. Discussion
Approximately 4%–8% of children with general body
trauma present with thoracic trauma. PC is the most
commonly identified thoracic injury in children. Because
of anatomical differences, children have twice as many
PCs as adults (15). PC can be defined as pulmonary
parenchymal damage with edema and hemorrhage
without vascular injury. Upon evaluation of the formation
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of PC, either direct parenchymal compression or sudden
and severe displacement of the mediastinal organs may
be determined as the cause of the contusion (1,16). The
present study utilized a modified version of the weight
reduction method described by Raghavendran et al. (13)
to create experimental PC. Using such method, we applied
direct pressure on the parenchyma, causing the mediastinal
structures to be displaced by the severity of the trauma.
Histopathological examination revealed that edema,
hemorrhage, leukocyte infiltration, and total lung injury
score were higher in the SG than in the CG. Accordingly,
statistically significant differences between both groups
proved that our experimental model was appropriate.
Complications such as pneumothorax, hemothorax,
atelectasis, consolidation, and pneumonia, which may
develop after PC, are determinants of mortality and
morbidity (17). In a study by Peclet et al., the mortality
rate in children with thoracic injuries was 26% (18).
Interstitial/intraalveolar edema, perivascular/intraalveolar

DEMİREL et al. / Turk J Med Sci
hemorrhage, and perivascular/interstitial leukocyte
infiltration play a key role in pulmonary congestion
complications. Edema, hemorrhage, and inflammation in
the parenchyma after PC disrupt the ventilation perfusion
rate and lead to hypoventilation and consequently hypoxia
(19). For this reason, many researchers have considered
such criteria in their work. Aksu et al. were able to
reduce edema, hemorrhage, and leukocyte infiltration by
applying sphingosylphosphorylcholine in an experimental
PC model (20). In another experimental study, dimethyl
sulfoxide was reported to reduce neutrophil infiltration
in the parenchyma after PC (21). Furthermore, Ateş et al.
suggested in their experimental study that levosimendan
may reduce neutrophil infiltration in damaged pulmonary
tissue, thereby reducing systemic inflammatory response
(22).
Salbutamol, the most commonly used bronchodilator
for asthma and obstructive lung disease (23), has been the
subject of many clinical and experimental studies because
of its ease of use, good recognition, and clearly known side
effects. In addition to the known effects of salbutamol,
Yilmaz et al. emphasized that polymorphonuclear
neutrophil leukocytes, interstitial/intraalveolar edema,
perivascular and/or intraalveolar hemorrhage, and hyaline
membrane formation were reduced (24). In a clinical
trial involving acute lung injury, inhaled salbutamol
was reported to reduce respiratory acidity while having
antiinflammatory activity (7). Although some authors
argue that β2-adrenergic agonists are useful during acute
lung injury, others reported that routine doses of β2agonists cannot be recommended for acute lung injury
(11,25,26).
In the present study, edema, hemorrhage, and total
lung injury scores in the treatment groups were similar to
those in the CG with no statistically significant difference
between them. In other words, the improvement was
comparable to that of normal lung parenchyma. In the
SG, total lung injury scores due to edema, hemorrhage,
and leukocyte infiltration were moderate and severe, all of
which were mild in our treatment groups. Statistical analysis

showed that salbutamol inhaler therapy had no significant
effect on leukocyte infiltration while reducing edema
and hemorrhage in our experimental PC model, which
was contrary to our expectation that salbutamol therapy
would cause significantly reduced neutrophil infiltration.
Our findings revealed that neutrophil infiltration scores
were lower in the treatment groups than in the SG, though
such results were not statistically significant. When we
evaluated edema, hemorrhage, and leukocyte infiltration
together in the total lung injury score, the results of our
treatment groups became even more meaningful. High
scores as in the SG were not seen in our treatment groups.
Our treatment groups were similar with undamaged lung
tissue.
We also aimed with this study to alter the duration of
salbutamol treatment, comparing groups with different
treatment durations. A longer treatment duration was
found to have reduced leukocyte infiltration with no
difference in the development of edema and hemorrhage.
Total lung injury scores showed that long-term treatment
was more effective.
The prevalence of edema and hemorrhage may change
according to the severity of the trauma. Hemorrhage and
parenchymal mucous secretion, which lead to atelectasis
and consolidation, may develop in the contralateral lung
without contusion (27). In the present study, we observed
that salbutamol inhaler therapy had a negative effect on
the scores of the contralateral lung tissue.
The most significant finding of the present study is that
salbutamol can be used alone or in combination with other
treatments for PC in either experimental or clinical trials.
In conclusion, salbutamol inhaler therapy may be an
effective treatment for reducing morbidity and mortality
during PC. Inhaler therapy once every 4 h for 3 days
may reduce inflammation more than 1 day of therapy.
Moreover, on the basis of the results presented here,
future prospective clinical trials are encouraged to include
salbutamol, which has been known for its ease of use and
clearly known side effects.
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